Form 4 for AMAL Amalgamated Financial Corp.
Accepted 2025-11-03 00:00:00 ET · period of report 2025-10-30 · accession 0001847223-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-03 | 2025-10-30 | AMAL | Kelly Julie | Dir | F - Tax | $27.56 | -6,310 | 23.5K | -21% | -$173.9K |
| DM | 2025-11-03 | 2025-10-30 | AMAL | Kelly Julie | Dir | M - OptEx | $13.38 | +13.0K | 25.4K | +105% | +$173.9K |
| D | 2025-11-03 | 2025-11-01 | AMAL | Kelly Julie | Dir | A - Grant | $0.00 | +2,311 | 19.1K | +14% | $0 |
| D | 2025-11-03 | 2025-10-31 | AMAL | Kelly Julie | Dir | S - Sale+OE | $27.34 | -6,697 | 16.8K | -29% | -$183.1K |
| DM | 2025-11-03 | 2025-10-30 | AMAL | Kelly Julie | Dir | M - OptEx | $0.00 | -13.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-30 | F | D | 2,048 | $27.56 | 21,422 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-30 | M | A | 4,220 | $13.75 | 23,470 | D | — | — | |
| 3 | Common | Common Stock | 2025-10-30 | F | D | 2,340 | $27.56 | 19,250 | D | — | — | |
| 4 | Common | Common Stock | 2025-10-30 | M | A | 4,820 | $12.00 | 21,590 | D | — | — | |
| 5 | Common | Common Stock | 2025-11-01 | A | A | 2,311 | $0.00 | 19,074 | D | — | — | (F2) The reported transaction involved the reporting person's receipt of a grant of 2,311 restricted stock units. The restricted stock units vest immediately upon grant, in consideration of the Company's termination of the stock option program and the Director's early exercise of all outstanding and vested stock options on October 30, 2025. |
| 6 | Common | Common Stock | 2025-10-31 | S | D | 6,697 | $27.34 | 16,763 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 - $27.635 . The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. |
| 7 | Common | Common Stock | 2025-10-30 | F | D | 1,922 | $27.56 | 23,460 | D | — | — | |
| 8 | Common | Common Stock | 2025-10-30 | M | A | 3,960 | $14.65 | 25,382 | D | — | — | |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-10-30 | M | D | 4,220 | $0.00 | 0 | D | $13.75 · 2017-01-01 to 2027-01-01 | 4,220 Common Stock | |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-10-30 | M | D | 4,820 | $0.00 | 0 | D | $12.00 · 2016-01-01 to 2026-01-01 | 4,820 Common Stock | |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-10-30 | M | D | 3,960 | $0.00 | 0 | D | $14.65 · 2018-01-01 to 2028-01-01 | 3,960 Common Stock |